According to Altimmune's latest financial reports the company's current revenue (TTM ) is ยฃ0.01 Million. a decrease over the revenue in the year 2023 that were of ยฃ0.33 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | ยฃ0.01 M | -95.23% |
2023 | ยฃ0.33 M | -694.9% |
2022 | -ยฃ0.06 Million | -101.72% |
2021 | ยฃ3.26 M | -45.58% |
2020 | ยฃ6 M | 35.73% |
2019 | ยฃ4.42 M | -68.9% |
2018 | ยฃ14.22 M | 46228.12% |
2017 | ยฃ0.03 M | -98.34% |
2016 | ยฃ1.85 M | -74.17% |
2015 | ยฃ7.18 M | 9.7% |
2014 | ยฃ6.54 M | -39.73% |
2013 | ยฃ10.85 M | -30.28% |
2012 | ยฃ15.57 M | -0.23% |
2011 | ยฃ15.61 M | 14.8% |
2010 | ยฃ13.59 M | -20.12% |
2009 | ยฃ17.02 M | -24.18% |
2008 | ยฃ22.45 M | 206.56% |
2007 | ยฃ7.32 M | 951.29% |
2006 | ยฃ0.69 M |